Taking the “Failure” Out of Heart Failure

Pharmacists are valuable members of the multidisciplinary team approach to long-term management of heart failure (HF) and its health-related impacts with the goals of improving patient quality of life and preventing death. This activity will explore the updated universal definition of HF, including revised staging as well as new and revised classifications of HF according to left ventricular ejection fraction. Newly approved and emerging therapies for the treatment of chronic or worsening HF will be reviewed to assist pharmacists with clinical decision making for the initiation, titration, and monitoring of HF therapies for patients.